CClinicalTrials.gg
CompletedNCT01467843Updated Oct 13, 2017

Comparison of CAM and Conventional Mind-Body Therapies for Chronic Back Pain

A Phase 3 interventional study of Cognitive Behavioral Therapy and Mindfulness Based Stress Reduction in Low Back Pain, sponsored by Kaiser Permanente. Completed at 1 site in United States. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2017-10-13.

Sponsored by Kaiser Permanente · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
342
Allocation
Randomized
Ages
20 Years to 70 Years
Sex
All
01

Study summary

Although national expenditures on back pain treatments have increased substantially over the past decade, the health and functional status of persons suffering from back pain has deteriorated. This trial will evaluate the effectiveness, and cost-effectiveness, of a safe and relatively inexpensive "mind-body" therapy that has the potential to provide relief to some of the millions of Americans who continue to suffer from chronic back pain.

Read the detailed description

Chronic back pain remains one of the most common and challenging public health problems in the U.S.. Although the amount of money spent on back pain treatments has increased substantially over the past decade in the U.S., the health and functional status of persons suffering from back pain has deteriorated. There is a clear need to identify safe, effective, and cost-effective treatment options for this often debilitating and expensive problem. Some of the more promising treatments for chronic back pain include "mind-body" therapies that address both psychological and somatic aspects of the pain experience. This randomized trial will compare the effectiveness and cost-effectiveness of Mindfulness-Based Stress Reduction (MBSR), a well-established but inadequately-studied CAM mind-body therapy, with usual care for persons with chronic low back pain and dysfunction. This trial will also compare MBSR with a conventional mind-body therapy, Cognitive-Behavioral Therapy (CBT), which has been found to be a modestly to moderately effective treatment for chronic back pain. Should MBSR and/or CBT prove effective in this trial, the mechanisms (mediators) of the effects of these two different mind-body therapies on pain and dysfunction will be explored. Because CBT aims to alter patients' cognitive and behavioral responses to pain, whereas MBSR focuses on direct present moment experience and not on changing the thoughts or feelings about such experience, these two therapies are hypothesized to operate by different mechanisms. A total of 342 adults aged 20 through 70 years who have moderately to severely disabling chronic back pain will be recruited and randomized in equal proportions to MBSR, CBT, and treatment as usual (usual care). Both the MBSR and CBT interventions will be provided to groups of up to 15 participants once a week for 8 weeks. The primary outcomes will be back pain-related functional limitations (Roland scale) and pain bothersomeness (rated on a 0-10 scale). Secondary outcomes include depression, anxiety, perceived stress, pain interference with activities, and sleep disturbance. Outcomes will be measured 4, 8, 26, and 52 weeks after randomization. If MBSR is at least moderately more effective than usual care, this safe and relatively inexpensive therapy would provide an appealing treatment option for chronic back pain that could be made more widely available. Because of the high prevalence and costs of chronic back pain, treatments with even modest impact on pain and function could produce a large benefit on a population level.

02

Conditions studied

  • Low Back Pain

Keywords

  • Cognitive Behavioral Therapy
  • Mindfulness Based Stress Reduction
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's enrollment of 342 is above the median of 60 across 1,941 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Kaiser Permanente is the lead sponsor of 385 studies on the registry; 41 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 3 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • clinical Diagnosis of Low Back Pain lasting at least 3 months
  • pain of at least 4 on a 0-10 bothersomeness scale

Exclusion criteria

Exclusion Criteria:

  • do not currently have back pain
  • current back pain episode less then 3 months in duration
  • current back pain is only reported as mild in dysfunction and symptoms (i.e., less than a score of 7 on the 0-23 modified Roland Scale or a bothersomeness score lower than 4 on a 0-10 scale);
  • sciatica
  • underlying systemic or visceral disease
  • pregnancy
  • abdominal aneurisms
  • spondylolisthesis
  • discitis
  • spinal stenosis
  • spinal infections
  • cancer or unexplained weight loss
  • recent vertebral fracture
  • current or past participation in classes or therapies closely resembling our MBSR or CBT interventions for chronic pain
  • have physical problems that won't allow them to do yoga (i.e., gross obesity, severe pain when bending or twisting, unable to get up and down from the floor)
  • involved with litigation or compensation claim for back pain
  • evidence of severe or progressive neurologic deficits
  • radiculopathy
  • fibromyalgia diagnosis
  • rheumatoid arthritis
  • back surgery within the last 2 years
  • unstable medical or severe psychiatric conditions
  • unable to speak or read English
  • unable to hear
  • plan to move out of town
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
342 participants (actual)

Study arms

  • Active comparator
    Cognitive Behavioral Therapy

    Participants randomized to the CBT intervention will attend eight weekly 2 hour sessions.

    Behavioral: Cognitive Behavioral Therapy

  • Active comparator
    Mindfulness-Based Stress Reduction

    Participants randomized to the MBSR arm will attend eight weekly 2 hour MBSR sessions.

    Behavioral: Mindfulness Based Stress Reduction

  • No intervention
    Usual Care

    Participants randomized to Usual Care will continue to receive care for their low back pain as prescribed by his/her Primary Care Physician.

Interventions

  • BehavioralCognitive Behavioral Therapy

    The Cognitive Behavioral Therapy Intervention will be delivered during 8 weekly classes each lasting 2 hours. The classes will be held at a conveniently located Group Health Facility.

  • BehavioralMindfulness Based Stress Reduction

    The Mindfulness Based Stress Reduction Classes will be delivered in 8 weekly classes each lasting 2 hours.

06

What researchers measure

Primary outcomes

  1. Back pain-related dysfunction

    Back-related dysfunction will be measured with the modified Roland Disability Questionnaire ("Roland scale"), which asks whether 23 specific activities were limited due to back pain during the past week (yes or no). This measure has been found to be reliable, valid and sensitive to clinical changes and is appropriate for telephone administration and patients with moderate disability.

    Time frame: 26 weeks

  2. Bothersomeness of back pain

    Symptom bothersomeness will be measured by asking participants to rate how "bothersome" their back pain has been during the previous week on a 0 to 10 scale (0 = "not at all bothersome" and 10 = "extremely bothersome"). This question worked well in our previous trials and is highly correlated with a 0-10 measure of pain intensity (r=0.8 to 0.9). It is also highly correlated with measures of function and other outcome measures.

    Time frame: 26 weeks

07

Study locations

1 site
  • Group Health Cooperative
    Seattle, Washington 98101, United States
08

References and documents

Publications

  • Chen JA, Anderson ML, Cherkin DC, Balderson BH, Cook AJ, Sherman KJ, Turner JA. Moderators and Nonspecific Predictors of Treatment Benefits in a Randomized Trial of Mindfulness-Based Stress Reduction vs Cognitive-Behavioral Therapy vs Usual Care for Chronic Low Back Pain. J Pain. 2023 Feb;24(2):282-303. doi: 10.1016/j.jpain.2022.09.014. Epub 2022 Sep 28. PubMed 36180008 ↗
  • Cherkin DC, Sherman KJ, Balderson BH, Cook AJ, Anderson ML, Hawkes RJ, Hansen KE, Turner JA. Effect of Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy or Usual Care on Back Pain and Functional Limitations in Adults With Chronic Low Back Pain: A Randomized Clinical Trial. JAMA. 2016 Mar 22-29;315(12):1240-9. doi: 10.1001/jama.2016.2323. PubMed 27002445 ↗
  • Cherkin DC, Sherman KJ, Balderson BH, Turner JA, Cook AJ, Stoelb B, Herman PM, Deyo RA, Hawkes RJ. Comparison of complementary and alternative medicine with conventional mind-body therapies for chronic back pain: protocol for the Mind-body Approaches to Pain (MAP) randomized controlled trial. Trials. 2014 Jun 7;15:211. doi: 10.1186/1745-6215-15-211. PubMed 24906419 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 13, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01467843
Lead sponsor
Kaiser Permanente
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Responsible party
Sponsor
First posted
Nov 9, 2011
Start date
Jun 2012
Primary completion
Nov 2015
Completion
Nov 2015
Last update
Oct 13, 2017

Study contacts

Daniel Cherkin, PhD
principal investigator · Kaiser Permanente

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion